Android app Apple app link

Vertex Pharmaceuticals Incorporated (VRTX) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$450.78
Day's range
$461.26

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
05/27/2026 Truist Financial Danielle Brill $542.00 $435.93   24.33%
05/05/2026 RBC Capital Brian Abrahams $543.00 $429.85   26.32%
03/10/2026 Truist Financial Joon Lee $525.00 $499.14   5.18%
03/10/2026 Jefferies Akash Tewari $580.00 $496.50   16.82%
03/02/2026 BMO Capital Evan David Seigerman $600.00 $487.57   23.06%
02/17/2026 Barclays Eliana Merle $607.00 $491.47   23.51%
02/17/2026 H.C. Wainwright Andrew Fein $591.00 $491.47   20.25%
02/13/2026 Morgan Stanley Terence Flynn $570.00 $497.42   14.59%
02/13/2026 Scotiabank Louise Chen $558.00 $493.98   12.96%
02/13/2026 Stifel Nicolaus Paul Matteis $466.00 $465.02   0.21%
02/13/2026 H.C. Wainwright Andrew Fein $518.00 $465.02   11.39%
01/23/2026 Evercore ISI Cory Kasimov $530.00 $469.11   12.98%
01/22/2026 RBC Capital Brian Abrahams $546.00 $461.14   18.4%
01/06/2026 UBS Michael Yee $535.00 $468.38   14.22%
12/03/2025 Morgan Stanley Terence Flynn $516.00 $433.15   19.13%
11/04/2025 Cantor Fitzgerald Carter Gould $485.00 $427.30   13.5%
11/04/2025 Barclays Gena Wang $414.00 $426.00   -2.82%
08/05/2025 UBS Eliana Merle $553.00 $374.98   47.47%
06/17/2025 RBC Capital Brian Abrahams $420.00 $441.99   -4.98%
05/06/2025 Scotiabank Greg Harrison $442.00 $450.03   -1.78%
01/31/2025 BMO Capital Evan Seigerman $545.00 $461.68   18.05%
01/30/2025 Wells Fargo Mohit Bansal $460.00 $441.52   4.19%
01/10/2025 Morgan Stanley Terence Flynn $456.00 $409.56   11.34%
12/19/2024 RBC Capital Brian Abrahams $400.00 $469.22   -14.75%
12/09/2024 Jefferies Michael Yee $550.00 $462.10   19.02%
11/05/2024 Oppenheimer Hartaj Singh $540.00 $499.10   8.19%
11/05/2024 RBC Capital Brian Abrahams $451.00 $499.88   -9.78%
10/22/2024 Canaccord Genuity Whitney Ijem $361.00 $478.09   -24.49%
10/21/2024 BMO Capital Evan David Seigerman $566.00 $485.74   16.52%
10/21/2024 Goldman Sachs Salveen Richter $598.00 $483.00   23.81%
10/14/2024 Bank of America Securities Geoff Meacham $541.00 $482.12   12.21%
10/09/2024 RBC Capital Brian Abrahams $437.00 $458.94   -4.78%
08/05/2024 Truist Financial Joon Lee $550.00 $494.46   11.23%
08/05/2024 Oppenheimer Hartaj Singh $550.00 $477.86   15.1%
08/05/2024 Wolfe Research Andy Chen $576.00 $476.91   20.78%
08/02/2024 H.C. Wainwright Andrew Fein $600.00 $505.78   18.63%
06/17/2024 Argus Research Jasper Hellweg $550.00 $474.61   15.88%
06/11/2024 RBC Capital Brian Abrahams $421.00 $483.28   -12.89%
05/31/2024 BMO Capital Evan David Seigerman $500.00 $443.05   12.85%
05/07/2024 Raymond James Christopher Raymond $456.00 $413.42   10.3%
05/07/2024 RBC Capital Brian Abrahams $424.00 $402.50   5.34%
04/11/2024 H.C. Wainwright Andrew Fein $462.00 $397.58   16.2%
04/11/2024 Evercore ISI Liisa Bayko $438.00 $397.58   10.17%
07/12/2022 Cantor Fitzgerald Olivia Brayer $365.00 $290.01   25.86%
07/11/2022 Stifel Nicolaus Paul Matteis $240.00 $295.46   -18.77%
05/03/2022 Morgan Stanley Matthew Harrison $250.00 $261.96   -4.57%
03/21/2022 Robert W. Baird Brian Skorney $240.00 $251.88   -4.72%
03/21/2022 BMO Capital Evan Seigerman $274.00 $251.88   8.78%
01/26/2022 Jefferies Michael Yee $275.00 $228.22   20.5%
01/26/2022 Wolfe Research Andrew Galler $282.00 $228.22   23.56%
01/26/2022 J.P. Morgan Cory Kasimov $288.00 $228.22   26.19%
01/26/2022 Morgan Stanley Matthew Harrison $208.00 $228.22   -8.86%
01/23/2022 Cowen & Co. Phil Nadeau $300.00 $229.68   30.62%
12/01/2021 Leerink Partners Geoff Porges $175.00 $204.45   -14.4%
11/30/2021 Guggenheim Debjit Chattopadhyay $286.00 $205.00   39.51%
11/01/2021 Bank of America Securities Geoff Meacham $275.00 $181.40   51.6%
06/10/2021 Cantor Fitzgerald Alethia Young $281.00 $193.02   45.58%
06/10/2021 Barclays Gena Wang $285.00 $193.02   47.65%
05/11/2021 UBS Colin Bristow $279.00 $212.68   31.18%

Vertex Pharmaceuticals, Inc. FAQ's

Vertex Pharmaceuticals, Inc. has been rated by research analysts at Truist Financial, Barclays, Cantor Fitzgerald, Canaccord Genuity, Stifel Nicolaus, UBS in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.